NCT04470232

Brief Summary

The management of coxofemoral pathologies is constantly increasing. In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (\<60 years). Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment. For the evaluation of coxofemoral pathologies in the young subject (\<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated. In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated. These two scores are useful in current clinical practice but they are only validated in English.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
2 countries

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 11, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

June 13, 2022

Status Verified

December 1, 2021

Enrollment Period

2 years

First QC Date

July 9, 2020

Last Update Submit

June 10, 2022

Conditions

Keywords

Coxofemoral pathologiesSelf assessment questionnaireSuper Simple Hip score (SUSHI-score)Hip disability and Osteoarthritis Outcome Score (HOOS score)Transcultural validationPsychometric validationHip and Groin score (HAGOS)

Outcome Measures

Primary Outcomes (2)

  • Transcultural validation of the SUSHI-score and HOOS-12 score questionnaire

    It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.

    1 month

  • Psychometric validation of the SUSHI-score and HOOS-12 score questionnaire

    Questionnaires will be passed by 120 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.

    12 months

Study Arms (1)

Patients with coxofemoral pathologies

For the transcultural validation, a french version of the 2 self-assessment questionnaires, SUSHI-score and the HOOs-12 score will be produced. For the psychometric validation, 120 patients with coxofemoral pathologies will pass the two questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Other: Self-assessment questionnaires

Interventions

120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Patients with coxofemoral pathologies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a coxofemoral pathology.

You may qualify if:

  • Adult patient (age greater than or equal to 18 years old),
  • Patient with coxofemoral pathology,
  • Patient having been informed of the research,
  • Patient agreeing to participate in the study.

You may not qualify if:

  • Minor patient,
  • Pregnant woman,
  • Patient out of state to agree to participate in the study,
  • Patient unable to answer a self-assessment questionnaire,
  • Patient under justice, guardianship or curatorship,
  • Patient who refused to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hôpital Lariboisière - AP-HP

Paris, 75010, France

RECRUITING

Centre Hospitalier Privé Saint-Grégoire

Saint-Grégoire, 35760, France

RECRUITING

CHU of Martinique

Fort-de-France, 97261, Martinique

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2020

First Posted

July 14, 2020

Study Start

September 11, 2020

Primary Completion

September 1, 2022

Study Completion

March 1, 2023

Last Updated

June 13, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations